{{Rsnum
|rsid=713330
|Gene=CD44
|Chromosome=11
|position=35202398
|Orientation=plus
|GMAF=0.2006
|Gene_s=CD44
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 13.8 | 44.6 | 41.5
| HCB | 2.3 | 13.6 | 84.1
| JPT | 0.0 | 4.5 | 95.5
| YRI | 0.0 | 12.7 | 87.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.3 | 13.6 | 84.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22788972
|Title=CD44 rs13347 C&gt;T polymorphism predicts breast cancer risk and prognosis in Chinese populations
|OA=1
}}

{{PMID Auto
|PMID=23883608
|Title=Polymorphisms of CD44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}